Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
06 Mar 2021
Historique:
accepted: 02 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 9 7 2021
Statut: ppublish

Résumé

Hereditary Spherocytosis (HS) is the most common erythrocyte membrane disorder causing hemolytic anemia. The wide heterogeneity of both clinical and laboratory manifestations of HS contributes to difficulties associated with the diagnosis of this disorder. Although massive data previously reported worldwide, there is yet no data on HS among the Tunisian population. Here we aim to characterize HS in Tunisian patients at biochemical and cellular levels, identify the membrane protein deficiency, and compare the accuracy of the diagnostic tests to identify the most appropriate assay for HS diagnosis. We investigated 81 patients with hemolytic anemia and 167 normal controls. The exploration of HS based on clinical and family history, physical examination, and the results of laboratory tests: blood smear, osmotic fragility test (OFT), cryohemolysis test (CT), pink test (PT), eosine-5'-maleimide (EMA) test, and erythrocyte membrane protein electrophoresis. We identified 21 patients with HS, classified as severe (6/21;28.5%), moderate (10/21;47.6%), and mild (5/21;23.8%). The most prevalent protein deficiency was the band 3 protein detected in ten Tunisian HS patients. The EMA test showed a high specificity (97.5%) and sensitivity (94.7%) for HS diagnosis compared to the other screening tests. Interestingly, fourteen among sixteen patients presenting with homozygous sickle cells HbSS showed an increase of EMA fluorescence intensity compared to other anemic patients. Our study highlights the efficiency of the EMA dye for the detection of HS whatever the nature of the involved protein deficiency. We report for the first time, the most prevalent protein deficiency among Tunisians with HS. Moreover, we found that the combination of the EMA-binding test with PT or incubated OFT improves the diagnosis sensitivity while maintaining a good specificity.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
Hereditary Spherocytosis (HS) is the most common erythrocyte membrane disorder causing hemolytic anemia. The wide heterogeneity of both clinical and laboratory manifestations of HS contributes to difficulties associated with the diagnosis of this disorder. Although massive data previously reported worldwide, there is yet no data on HS among the Tunisian population. Here we aim to characterize HS in Tunisian patients at biochemical and cellular levels, identify the membrane protein deficiency, and compare the accuracy of the diagnostic tests to identify the most appropriate assay for HS diagnosis.
METHODS METHODS
We investigated 81 patients with hemolytic anemia and 167 normal controls. The exploration of HS based on clinical and family history, physical examination, and the results of laboratory tests: blood smear, osmotic fragility test (OFT), cryohemolysis test (CT), pink test (PT), eosine-5'-maleimide (EMA) test, and erythrocyte membrane protein electrophoresis.
RESULTS RESULTS
We identified 21 patients with HS, classified as severe (6/21;28.5%), moderate (10/21;47.6%), and mild (5/21;23.8%). The most prevalent protein deficiency was the band 3 protein detected in ten Tunisian HS patients. The EMA test showed a high specificity (97.5%) and sensitivity (94.7%) for HS diagnosis compared to the other screening tests. Interestingly, fourteen among sixteen patients presenting with homozygous sickle cells HbSS showed an increase of EMA fluorescence intensity compared to other anemic patients.
CONCLUSION CONCLUSIONS
Our study highlights the efficiency of the EMA dye for the detection of HS whatever the nature of the involved protein deficiency. We report for the first time, the most prevalent protein deficiency among Tunisians with HS. Moreover, we found that the combination of the EMA-binding test with PT or incubated OFT improves the diagnosis sensitivity while maintaining a good specificity.

Identifiants

pubmed: 33667330
doi: 10.33594/000000333
doi:

Substances chimiques

Membrane Proteins 0
eosin maleimide 76296-42-9
Eosine Yellowish-(YS) TDQ283MPCW

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-129

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Auteurs

Nawel Trabelsi (N)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie, nawel.trabelsi@pasteur.utm.tn.
Faculté des Sciences de Tunis, Université de Tunis El Manar, Tunis, Tunisie.

Ghada Bouguerra (G)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.
Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie.

Faten Haddad (F)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.
Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie.

Monia Ouederni (M)

Unité d'hématologie-immunologie pédiatrique, Centre National de Transplantation de la Moelle Osseuse, Tunis, Tunisie.

Imen Darragi (I)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Imen Boudrigua (I)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Dorra Chaouachi (D)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Mbarka Barmat (M)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Chaker Fouzai (C)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Mohamed Bejaoui (M)

Unité d'hématologie-immunologie pédiatrique, Centre National de Transplantation de la Moelle Osseuse, Tunis, Tunisie.

Samia Menif (S)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Imen Kraiem (I)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.

Salem Abbes (S)

Laboratoire d'Hématologie Moléculaire et Cellulaire (LR16IPT07), Institut Pasteur de Tunis, Tunis, Tunisie.
Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH